Cantai Therapeutics, Inc.

Industry: Biotechnology (See others in industry)

Address:
3675 Market Street Suite 200
Philadelpia, PA, 19104
Phone: 603-996-1218

Filings

Date Type Incremental Cash Raw Filing
2025-07-15 New $550,000 SEC link
2023-11-20 New $700,000 SEC link
2023-11-20 Amended $0 SEC link

Directors and Executives (Current and Past)

Name Role
Errik Anderson Director, Executive
Joshua Brandt Director
Ross Leimberg Director, Executive
Geeta Vemuri Director, Executive